| scholarly article | Q13442814 |
| P2093 | author name string | Stefka Vladeva | |
| Ana Maneva | |||
| Ginka Delcheva | |||
| Teodora Stankova | |||
| P2860 | cites work | Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease | Q28260195 |
| Effects of Berberine on Expression of LOX-1 and SR-BI in Human Macrophage-Derived Foam Cells Induced by ox-LDL | Q28297920 | ||
| Protein carbamylation links inflammation, smoking, uremia and atherogenesis. | Q30364367 | ||
| Carbamoylation of amino acids and proteins in uremia | Q31905731 | ||
| Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome | Q33788524 | ||
| Myeloperoxidase and cardiovascular disease. | Q34406359 | ||
| Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome | Q34461362 | ||
| Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation | Q34546113 | ||
| Resveratrol Attenuates Oxidized LDL-Evoked Lox-1 Signaling and Consequently Protects against Apoptotic Insults to Cerebrovascular Endothelial Cells | Q34714771 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan | Q73067288 | ||
| Identification of soluble forms of lectin-like oxidized LDL receptor-1 | Q73536903 | ||
| Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors | Q73675694 | ||
| Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis | Q80976759 | ||
| Quantification of carbamylated LDL in human sera by a new sandwich ELISA | Q81346653 | ||
| Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase | Q81721135 | ||
| Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome | Q82753008 | ||
| Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells | Q83178943 | ||
| Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease | Q83466551 | ||
| Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals | Q36049150 | ||
| Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor | Q36394675 | ||
| Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women | Q37181325 | ||
| Carbamylated LDL | Q37790669 | ||
| Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease | Q37971422 | ||
| LOX-1, a new marker of risk and prognosis in coronary artery disease? | Q38128195 | ||
| Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium | Q38353224 | ||
| Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus. | Q38395463 | ||
| Oxidized LDL Is Associated With Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance. | Q39086114 | ||
| LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation | Q39344615 | ||
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | Q39513420 | ||
| Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study | Q40196845 | ||
| The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort | Q40521867 | ||
| Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. | Q41541678 | ||
| Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose | Q43251569 | ||
| Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study | Q44513183 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI. | Q45045801 | ||
| Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men. | Q45932493 | ||
| Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus | Q46405281 | ||
| Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion | Q46470697 | ||
| Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease | Q46545487 | ||
| Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. | Q46563174 | ||
| Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus | Q46648050 | ||
| Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease | Q46681831 | ||
| Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women | Q46766135 | ||
| Carbamylated low-density lipoprotein induces endothelial dysfunction | Q46915576 | ||
| Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis | Q48320976 | ||
| Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome | Q49991541 | ||
| Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack | Q50059271 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| coronary artery disease | Q844935 | ||
| P577 | publication date | 2019-08-15 | |
| P1433 | published in | Medicina | Q26842055 |
| P1476 | title | Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome | |
| P478 | volume | 55 |
Search more.